Subject Database
Clinilabs Drug Development Corporation provides access to the world’s largest population of racially diverse clinical trial participants. We recruit healthy volunteers, patients, and specialty groups from a population of more than 19 million people in the New York metropolitan area. Our on-site call center employs highly-experienced, multilingual associates who pre-screen study candidates using the latest technology in order to ensure that our proprietary database is the most robust in the industry. We currently have more than 24,000 study candidates in our database. Click here to determine if our database includes the subject population that you are seeking.
Clinilabs promotes gender and racial diversity in clinical trials, which we conduct to develop new therapies for the CNS disorders listed below.
Normal Healthy Subjects
Healthy adults
Healthy elderly
Psychiatric Disorders
Sleep disorders
Affective disorder
Anxiety disorders
Schizophrenia
Depressive disorders
Post-tramatic stress disorders
Neurological Disorders
Alzheimer’s disease
Dementia
Cognition
Headache
Epilepsy
Movement disorders
Tramatic brain injury
Sleep Disorders
Insomnia
Sleep apnea
Narcolepsy
Excessive sleepiness
Circadian rhythm disorders
Endocrine and Metabolic Disorders
Diabetes
Obesity
Infectious disease
HIV
Hepatitis B
Hepatitis C
Dermatologic disorders
Psoriasis
Rosacea
Pulmonary Disease
Asthma
COPD
Men’s and Women’s Health
Erectile dysfunction
Low-T
Menopause
Rare Disorders
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
– George W. Merck